Pfizer and Valneva to Seek Approval for Lyme Disease Vaccine

Pharmaceutical giants Pfizer and French partner Valneva announced plans to seek regulatory approval for their Lyme disease vaccine following successful late-stage trial results.

23 Mar, 11:07 — 23 Mar, 11:07

Post Share

Sources

Showing 1 of 1 sources

marketwatchMostly Factual1h ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease vaccine after a late-stage trial.

By Steve Goldstein

Read full article →

PERSPECTA

PERSPECTA

Pfizer and Valneva to Seek Approval for Lyme Disease Vaccine

Sources

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Related Stories

Counsel Seeks Exclusion of Atong Ang from Manila 'Sabungeros' Case

Philippine Education Department Mandates Modest Graduation Rites Amid Fuel Price Surge

Mega Prime Foods Partners with Thailand's Largest Conglomerate for Egg Production

Philippines Faces Milder Oil Price Hikes and Record Peso Low

PERSPECTA